Trials / Completed
CompletedNCT06940895
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Narrows Institute for Biomedical Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the safety and efficacy of Sirolimus 0.2% topical gel for patients with Acanthosis Nigricans
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sirolimus 0.2% | sirolimus 0.2% gel |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2025-07-08
- Completion
- 2025-07-18
- First posted
- 2025-04-23
- Last updated
- 2025-11-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06940895. Inclusion in this directory is not an endorsement.